Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DePuy Synthes inks co-op deal with trauma surgeon network

This article was originally published in Clinica

Executive Summary

DePuy Synthes has signed a five-year co-operation agreement with the AO Foundation to help boost the orthopedics group’s credibility and raise awareness of its new products through the latter’s global network of surgeons. The AO Foundation is a medically-guided non-profit organization that aims to educate and promote innovative surgical technologies and methodologies to surgeons worldwide through its educational programs. Through this collaboration, new products that emerge from DePuy Synthes’ portfolio – and certified by the AO Technical Commission – will be used in AO educational activities; over 200,000 health care professionals are expected to participate in AO program globally over the next five years, according to DePuy Synthes. The AO Foundation has already had a long-standing partnership with Synthes prior to the company’s acquisition by DePuy in 2012.

You may also be interested in...

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts